Expression of MHC class II antigen is essential in tolerance induction by donor bone marrow cell in antilymphocyte serum-treated and rapamycin-treated mice.
Transplant Center, Beth Israel Deaconess Medical Center and Harvard Medial School, Boston, Massachusetts, USA.
A
A
Umemura
A P
AP
Monaco
T
T
Maki
D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D016026:Bone Marrow Transplantation / Q000276:immunology*; D006085:Graft Survival; D015395:Histocompatibility Antigens Class I / Q000276:immunology / Q000378:metabolism; D000949:Histocompatibility Antigens Class II / Q000276:immunology* / Q000378:metabolism; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D020123:Sirolimus / Q000494:pharmacology; D013601:T-Lymphocytes / Q000276:immunology*; D013997:Time Factors; D023001:Transplantation Tolerance / Q000276:immunology*
D000961:Antilymphocyte Serum; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II; D007166:Immunosuppressive Agents; D020123:Sirolimus